Stock Events

Edwards Lifesciences 

$87.98
180
+$0.52+0.59% Friday 20:00

Statistics

Day High
88.32
Day Low
87.28
52W High
96.12
52W Low
60.57
Volume
1,766,013
Avg. Volume
2,608,408
Mkt Cap
53.02B
P/E Ratio
37.76
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25JulConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Next
0.59
0.63
0.66
0.7
Expected EPS
0.696217
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap109.27B
Medtronic competes directly with Edwards Lifesciences in the heart valve market, including transcatheter aortic valve replacement (TAVR) technologies.
Boston Scientific
BSX
Mkt Cap111.19B
Boston Scientific competes in the interventional cardiology space, offering products that rival Edwards Lifesciences' heart valve solutions.
Abbott Laboratories
ABT
Mkt Cap180.83B
Abbott Laboratories offers a range of cardiovascular devices, including mitral and tricuspid valve repair and replacement technologies that compete with Edwards' offerings.
Stryker
SYK
Mkt Cap127.82B
Stryker competes in the medical devices sector, including neurotechnology and spine products, which can be seen as indirect competition to Edwards Lifesciences' cardiovascular focus.
Johnson & Johnson
JNJ
Mkt Cap353.71B
Johnson & Johnson, through its medical devices segment, competes across various healthcare sectors, including cardiovascular, which puts it in competition with Edwards Lifesciences.
Zimmer Biomet
ZBH
Mkt Cap23.95B
Zimmer Biomet, primarily known for orthopedics, has ventured into the cardiovascular space, positioning it as a competitor to Edwards Lifesciences.
Intuitive Surgical
ISRG
Mkt Cap143.6B
Intuitive Surgical's robotic-assisted surgical systems can be used in cardiovascular surgeries, indirectly competing with Edwards Lifesciences' surgical heart valve solutions.
Edwards Lifesciences
EW
Mkt Cap53.02B
Edwards Lifesciences competes with itself through its diverse range of heart valve products, constantly innovating to replace its older technologies.
Baxter International
BAX
Mkt Cap17.27B
Baxter International competes in the broader medical devices market, including products for critical care, which can overlap with Edwards Lifesciences' cardiovascular focus.
Integra Lifesciences
IART
Mkt Cap2.23B
Integra LifeSciences, while more focused on neurosurgery and regenerative technologies, competes in the medical devices market, offering some products that can be used in cardiovascular procedures.

Analyst Ratings

96.92$Average Price Target
The highest estimate is $105.
From 14 ratings within the last 6 months. This is not an investment recommendation.
Buy
79%
Hold
21%
Sell
0%

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Show more...
CEO
Michael Mussallem
Employees
19800
Country
US
ISIN
US28176E1082
WKN
000936853

Listings